Healio

Superior first-line prostate cancer treatment often not given due to ‘lack of awareness’

Please provide your email address to receive an email when new articles are posted on . Many men with metastatic hormone-sensitive prostate cancer have not received recommended first-line treatment.
Rutland Herald

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic ...
Healio

Prostate-specific antigen screening more cost effective than first-line MRI

Please provide your email address to receive an email when new articles are posted on . First-line biparametric MRI testing increased the number of biopsies and overdiagnoses vs. first-line PSA ...
Nasdaq

Cortechs.ai and EDAP TMS SA Announce Successful First OnQ Prostate-Assisted Focal One® HIFU Procedure at UCSF Prostate Cancer Center

The first OnQ Prostate-assisted Focal One® Robotic HIFU procedure was successfully performed at UCSF, improving prostate cancer treatment precision. Cortechs.ai and EDAP TMS have announced the ...
Medical Xpress

MRI-first strategy for prostate cancer detection proves deemed safe and effective

There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...
Medscape

Few Prostate CT Simulations Successful on First Attempt

Only 31% of patients with prostate cancer receiving radiation therapy had a successful CT simulation on the first attempt, while more than half required multiple scans on the same day and nearly 17% ...
TMCnet

Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized ...

Extended follow-up data from the phase 3 study (20 months after reported topline data, median follow-up 58 months) confirmed a statistically significant and clinically meaningful improvement in ...